Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07201948 · ClinicalTrials.gov registry record · NA

Team Lifestyle Immersion Hypertension Control Project

A NA study of Hypertension, sponsored by Meharry Medical College.

Recruiting
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT07201948: Recruiting NA study of Hypertension, sponsored by Meharry Medical College.

NCT07201948 is a NA study of Hypertension that is actively recruiting participants, run by Meharry Medical College. The registered enrollment target is 220 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07201948, a NA study of Hypertension, is actively recruiting participants, sponsored by Meharry Medical College.

RECRUITING
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic ailments such as heart disease, diabetes, kidney failure, and obesity, with similar control measures. Several clinical trials over the last five decades have emphasized the importance of supportive lifestyle modification in the control of chronic disease that include a healthy diet, physical activity, quitting tobacco use, reducing alcohol use to the minimum, self-management of the disease, and adequate sleep. Study participants will receive motivation and skill development support in additional to specific nutrition, physical fitness, and self-management counselling from certified experts. This intervention incorporates elements of the American Heart Association prescription for health, Life's Simple 7 (LS7) lifestyle modification, the Dietary Approaches to preventing Hypertension (DASH) eating plan. After receiving these interventions, participants will be contacted at 3-months, 6-months, and 12-months for follow-up. They will complete similar surveys to be compared to determine impact on their hypertension. This intervention is complementary to usual pharmaceutical hypertension management.

Primary Outcome

Systolic and Diastolic blood pressure change will be computed as: SBP (enrollment) - SBP (Follow-up) DBP (enrollment) - DBP (Follow-up)

Conditions Studied

Interventions

  • BEHAVIORAL Lifestyle Immersion Intervention that will address Nutrition, Physical Fitness, and BP Self-Monitoring3 Elements:

Study Locations (1)

Tennessee

  • Meharry Medical College - Nashville

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2025-06-01
Est. Completion 2028-04-30
Phase NA
Meharry Medical College

10 total trials

What NCT07201948 shows while recruiting

NCT07201948 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Immersion Intervention that will address Nutrition, Physical Fitness, and BP Self-Monitoring3 Elements: is the first listed.

NCT07201948 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT07201948 about?

NCT07201948 is a clinical study titled "Team Lifestyle Immersion Hypertension Control Project". This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic ailments such as heart disease, diabetes, kidney failure, and obesity, with similar control measures. Several clinical trials over the last fi...

What is the current status of trial NCT07201948?

This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2025-06-01. Estimated completion is 2028-04-30.

What conditions does trial NCT07201948 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT07201948?

The interventions under investigation include: Lifestyle Immersion Intervention that will address Nutrition, Physical Fitness, and BP Self-Monitoring3 Elements: (BEHAVIORAL).

Who is sponsoring clinical trial NCT07201948?

This trial is sponsored by Meharry Medical College, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07201948 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07201948's enrollment target sits among peer trials

220 206th of 470 higher than 262 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07201948, the US trial registry maintained by the National Library of Medicine. NCT07201948 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.